[
  {
    "sessionId": "11045",
    "sessionTitle": "Bone Marrow Failure: Inherited",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11045",
    "sessionTitle": "Bone Marrow Failure: Inherited",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11046",
    "sessionTitle": "Bone Marrow Failure: Acquired",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11046",
    "sessionTitle": "Bone Marrow Failure: Acquired",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11047",
    "sessionTitle": "Management of Sickle Cell Disease: Present and Future",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11047",
    "sessionTitle": "Management of Sickle Cell Disease: Present and Future",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11048",
    "sessionTitle": "Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11048",
    "sessionTitle": "Practical Aspects of Acute and Chronic Pain Management in Sickle Cell Disease",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11049",
    "sessionTitle": "Emerging Issues in Clinical Care in Thalassemia",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11049",
    "sessionTitle": "Emerging Issues in Clinical Care in Thalassemia",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11050",
    "sessionTitle": "Congenital and Acquired Neutropenia",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11050",
    "sessionTitle": "Congenital and Acquired Neutropenia",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11051",
    "sessionTitle": "Therapeutic Apheresis as an Immunomodulatory Tool",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11051",
    "sessionTitle": "Therapeutic Apheresis as an Immunomodulatory Tool",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11052",
    "sessionTitle": "The Changing Landscape of Hemophilia Therapy",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11052",
    "sessionTitle": "The Changing Landscape of Hemophilia Therapy",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11053",
    "sessionTitle": "Controversies in Venous Thromboembolism: To Treat or Not to Treat",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11053",
    "sessionTitle": "Controversies in Venous Thromboembolism: To Treat or Not to Treat",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11054",
    "sessionTitle": "Common Clinical Questions in Cancer-Associated Venous Thromboembolism",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11054",
    "sessionTitle": "Common Clinical Questions in Cancer-Associated Venous Thromboembolism",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11055",
    "sessionTitle": "Common Hematologic Consults in Pregnancy",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11055",
    "sessionTitle": "Common Hematologic Consults in Pregnancy",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11056",
    "sessionTitle": "Thrombocytopenia in Hospitalized Patients",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11056",
    "sessionTitle": "Thrombocytopenia in Hospitalized Patients",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11057",
    "sessionTitle": "Thrombosis, Devices, and Interventions",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11057",
    "sessionTitle": "Thrombosis, Devices, and Interventions",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11058",
    "sessionTitle": "It All Starts Here: Disorders of Primary Hemostasis",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11058",
    "sessionTitle": "It All Starts Here: Disorders of Primary Hemostasis",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11059",
    "sessionTitle": "Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11059",
    "sessionTitle": "Lessons Learned From Quality Improvement Initiatives in Sickle Cell Disease",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11060",
    "sessionTitle": "Emerging Pathogens from A to Zika and Their Impact on Transfusion Safety",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11061",
    "sessionTitle": "A Sticky Business: New Insights Into Neutrophil Extracellular Traps (NETs) in Physiology and Disease",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11062",
    "sessionTitle": "Debate: Patients With Acquired TTP in Remission Should Be Treated to Prevent Relapse",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11063",
    "sessionTitle": "Getting Patients to Transplant: Myths and Reality",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11064",
    "sessionTitle": "Novel Epigenetic Modifications in Cancer and Development",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11064",
    "sessionTitle": "Novel Epigenetic Modifications in Cancer and Development",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11065",
    "sessionTitle": "Primary Immunodeficiencies From Childhood to Adulthood",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11065",
    "sessionTitle": "Primary Immunodeficiencies From Childhood to Adulthood",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11066",
    "sessionTitle": "Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11066",
    "sessionTitle": "Genetic Pathways That Disrupt Hematopoietic Stem Cell Function in Inherited Bone Marrow Failure",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11067",
    "sessionTitle": "Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11067",
    "sessionTitle": "Next-Generation Sequencing in Routine Diagnostics: Are We There Yet?",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11068",
    "sessionTitle": "Hematopoietic Stem Cell Generation: Reprogramming and Expansion",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11068",
    "sessionTitle": "Hematopoietic Stem Cell Generation: Reprogramming and Expansion",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11069",
    "sessionTitle": "Impact of the Contact Pathway on Disease States: Molecular Mechanisms",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11069",
    "sessionTitle": "Impact of the Contact Pathway on Disease States: Molecular Mechanisms",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11070",
    "sessionTitle": "New Approaches to Understanding Microbial Immune System Interactions",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11070",
    "sessionTitle": "New Approaches to Understanding Microbial Immune System Interactions",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11071",
    "sessionTitle": "Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11071",
    "sessionTitle": "Iron Trafficking: Ins and Outs in Organelles, Organs, and Organisms",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11072",
    "sessionTitle": "Advances in Cellular Immunotherapy for Lymphoid Malignancies",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11072",
    "sessionTitle": "Advances in Cellular Immunotherapy for Lymphoid Malignancies",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11073",
    "sessionTitle": "New Innovations in Platelet Regulation of Tumor Growth and Metastasis",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11073",
    "sessionTitle": "New Innovations in Platelet Regulation of Tumor Growth and Metastasis",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11074",
    "sessionTitle": "Clonal Evolution in Myeloid Malignancies",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:30:00 AM"
  },
  {
    "sessionId": "11074",
    "sessionTitle": "Clonal Evolution in Myeloid Malignancies",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:30:00 AM"
  },
  {
    "sessionId": "11074",
    "sessionTitle": "Clonal Evolution in Myeloid Malignancies",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:30:00 AM"
  },
  {
    "sessionId": "11074",
    "sessionTitle": "Clonal Evolution in Myeloid Malignancies",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:30:00 AM"
  },
  {
    "sessionId": "11075",
    "sessionTitle": "The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11075",
    "sessionTitle": "The Yin and Yang of Myeloma: Understanding and Harnessing Normal Plasma Cell Biology to Better Treat Myeloma",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11077",
    "sessionTitle": "Presidential Symposium",
    "sessionStart": "9:45:00 AM",
    "sessionEnd": "11:15:00 AM"
  },
  {
    "sessionId": "11078",
    "sessionTitle": "ASH-EHA Joint Symposium",
    "sessionStart": "12:30:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11078",
    "sessionTitle": "ASH-EHA Joint Symposium",
    "sessionStart": "12:30:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11081",
    "sessionTitle": "ASH Practice Partnership Lunch",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:30:00 PM"
  },
  {
    "sessionId": "11083",
    "sessionTitle": "Special Symposium on Quality",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11083",
    "sessionTitle": "Special Symposium on Quality",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11084",
    "sessionTitle": "ASH Choosing Wisely® Campaign: 2017 ASH Choosing Wisely Champions",
    "sessionStart": "12:15:00 PM",
    "sessionEnd": "1:15:00 PM"
  },
  {
    "sessionId": "11085",
    "sessionTitle": "Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11085",
    "sessionTitle": "Special Education Session on New ASH Clinical Practice Guidelines on Venous Thromboembolism",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11086",
    "sessionTitle": "Quality Conversations on Social Media: Achieving Credibility and Efficiency Together",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11087",
    "sessionTitle": "AML MATTERS: A Multidisciplinary Approach To Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11088",
    "sessionTitle": "Global Hematology Symposium",
    "sessionStart": "12:15:00 PM",
    "sessionEnd": "1:15:00 PM"
  },
  {
    "sessionId": "11088",
    "sessionTitle": "Global Hematology Symposium",
    "sessionStart": "12:15:00 PM",
    "sessionEnd": "1:15:00 PM"
  },
  {
    "sessionId": "11089",
    "sessionTitle": "Blood and Beyond: The Art of Perception",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11090",
    "sessionTitle": "When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11090",
    "sessionTitle": "When Graft Versus Tumor Fails: The Biology and Treatment of Relapse After Allogeneic Stem Cell Transplantation",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11091",
    "sessionTitle": "Dilemmas in Pediatric Hematologic Malignancy",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11091",
    "sessionTitle": "Dilemmas in Pediatric Hematologic Malignancy",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11092",
    "sessionTitle": "Novel Therapeutics in Myeloma",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11092",
    "sessionTitle": "Novel Therapeutics in Myeloma",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11093",
    "sessionTitle": "Controversies in Myeloma",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11093",
    "sessionTitle": "Controversies in Myeloma",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11094",
    "sessionTitle": "Myelodysplastic Syndromes: Understanding the Current Treatment Landscape",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11094",
    "sessionTitle": "Myelodysplastic Syndromes: Understanding the Current Treatment Landscape",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11095",
    "sessionTitle": "Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11095",
    "sessionTitle": "Myeloproliferative Neoplasms: New Insights in the Current Treatment Paradigm",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11096",
    "sessionTitle": "Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11096",
    "sessionTitle": "Chronic Myeloid Leukemia: Where Are We in the Current TKI Era?",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11097",
    "sessionTitle": "Acute Lymphocytic Leukemia: New Approaches in Management",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11097",
    "sessionTitle": "Acute Lymphocytic Leukemia: New Approaches in Management",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11098",
    "sessionTitle": "Acute Myeloid Leukemia: How Can We Improve Upon “Standard” Therapy?",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11098",
    "sessionTitle": "Acute Myeloid Leukemia: How Can We Improve Upon “Standard” Therapy?",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11099",
    "sessionTitle": "Individualizing Therapy in Chronic Lymphocytic Leukemia",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11099",
    "sessionTitle": "Individualizing Therapy in Chronic Lymphocytic Leukemia",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11100",
    "sessionTitle": "The Challenge of Primary and Secondary Central Nervous System Lymphoma",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11100",
    "sessionTitle": "The Challenge of Primary and Secondary Central Nervous System Lymphoma",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11101",
    "sessionTitle": "The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11101",
    "sessionTitle": "The Expanding Role of Immunotherapy in Non-Hodgkin Lymphoma",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11102",
    "sessionTitle": "Evolving Strategies in Aggressive B-Cell Lymphoma",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11102",
    "sessionTitle": "Evolving Strategies in Aggressive B-Cell Lymphoma",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11103",
    "sessionTitle": "Hodgkin Lymphoma: New Insights and New Approaches",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11103",
    "sessionTitle": "Hodgkin Lymphoma: New Insights and New Approaches",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11104",
    "sessionTitle": "Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11104",
    "sessionTitle": "Indolent Lymphoma: How Understanding Disease Biology Is Influencing Clinical Decision-Making",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11105",
    "sessionTitle": "Identification and Management of Toxicities Induced by Immunotherapies",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11106",
    "sessionTitle": "Editing and Enhancing Erythropoiesis",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11106",
    "sessionTitle": "Editing and Enhancing Erythropoiesis",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11107",
    "sessionTitle": "Evolving Approaches to Gene Therapy for Blood Diseases",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11107",
    "sessionTitle": "Evolving Approaches to Gene Therapy for Blood Diseases",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11108",
    "sessionTitle": "Thrombosis: A View From the World of Bioengineering",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11108",
    "sessionTitle": "Thrombosis: A View From the World of Bioengineering",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11109",
    "sessionTitle": "Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11109",
    "sessionTitle": "Targeted for Destruction: Clearance and Hemostatic Activity of Endogenous and Transfused Platelets",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11110",
    "sessionTitle": "Targeting T-Cell Exhaustion",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11110",
    "sessionTitle": "Targeting T-Cell Exhaustion",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11111",
    "sessionTitle": "Special Scientific Symposium on Targeted Therapy: What Is the Best Target?",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11112",
    "sessionTitle": "Special Scientific Symposium on Understanding and Modulating the DNA Damage Response",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11113",
    "sessionTitle": "Special Symposium on the Basic Science of Hemostasis and Thrombosis",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:30:00 PM"
  },
  {
    "sessionId": "11113",
    "sessionTitle": "Special Symposium on the Basic Science of Hemostasis and Thrombosis",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:30:00 PM"
  },
  {
    "sessionId": "11113",
    "sessionTitle": "Special Symposium on the Basic Science of Hemostasis and Thrombosis",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:30:00 PM"
  },
  {
    "sessionId": "11114",
    "sessionTitle": "Special Scientific Symposium on Hot Topics in Hematology: New Pathways Linking Hematopoiesis, Thrombosis, and Cardiovascular Disease",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11115",
    "sessionTitle": "The Impact of the Microbiome on the Hematologic System: Thrombosis and Graft-Versus-Host Disease",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11116",
    "sessionTitle": "Beyond Sequencing: Emerging Tools for Analysis of Multi-Omic Genomic Data in Acquired and Inherited Hematologic Disease",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11139",
    "sessionTitle": "Trainee Day Didactic Session 1: Statistics and Trial Design",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:15:00 PM"
  },
  {
    "sessionId": "11159",
    "sessionTitle": "Trainee Didactic Session: Time Management and Balance",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11166",
    "sessionTitle": "K2R: Breakout 1: Basic Science",
    "sessionStart": "2:30:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11166",
    "sessionTitle": "K2R: Breakout 1: Basic Science",
    "sessionStart": "2:30:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11166",
    "sessionTitle": "K2R: Breakout 1: Basic Science",
    "sessionStart": "2:30:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11168",
    "sessionTitle": "K2R: Breakout 2: Clinical",
    "sessionStart": "2:30:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11168",
    "sessionTitle": "K2R: Breakout 2: Clinical",
    "sessionStart": "2:30:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11169",
    "sessionTitle": "K2R: Breakout 3: Education/ Epidemiology/ Health Services",
    "sessionStart": "2:30:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11169",
    "sessionTitle": "K2R: Breakout 3: Education/ Epidemiology/ Health Services",
    "sessionStart": "2:30:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11170",
    "sessionTitle": "K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:00:00 PM"
  },
  {
    "sessionId": "11170",
    "sessionTitle": "K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:00:00 PM"
  },
  {
    "sessionId": "11170",
    "sessionTitle": "K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:00:00 PM"
  },
  {
    "sessionId": "11170",
    "sessionTitle": "K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:00:00 PM"
  },
  {
    "sessionId": "11170",
    "sessionTitle": "K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:00:00 PM"
  },
  {
    "sessionId": "11170",
    "sessionTitle": "K2R: Panel Discussion: The Dollars and Sense of Pursuing an Academic Career: Your First Academic Position ",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:00:00 PM"
  },
  {
    "sessionId": "11177",
    "sessionTitle": "Hematology Course Directors’ Workshop",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11178",
    "sessionTitle": "Junior Faculty Development  Education Session: Grant Funding: How to Get It and How to Keep It Going",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11181",
    "sessionTitle": "Career Development Lunch Sessions: Room 1",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11217",
    "sessionTitle": "Networking Reception for Female Hematologists",
    "sessionStart": "7:30:00 PM",
    "sessionEnd": "9:00:00 PM"
  },
  {
    "sessionId": "11217",
    "sessionTitle": "Networking Reception for Female Hematologists",
    "sessionStart": "7:30:00 PM",
    "sessionEnd": "9:00:00 PM"
  },
  {
    "sessionId": "11217",
    "sessionTitle": "Networking Reception for Female Hematologists",
    "sessionStart": "7:30:00 PM",
    "sessionEnd": "9:00:00 PM"
  },
  {
    "sessionId": "11217",
    "sessionTitle": "Networking Reception for Female Hematologists",
    "sessionStart": "7:30:00 PM",
    "sessionEnd": "9:00:00 PM"
  },
  {
    "sessionId": "11220",
    "sessionTitle": "Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "9:45:00 AM"
  },
  {
    "sessionId": "11220",
    "sessionTitle": "Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "9:45:00 AM"
  },
  {
    "sessionId": "11220",
    "sessionTitle": "Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "9:45:00 AM"
  },
  {
    "sessionId": "11220",
    "sessionTitle": "Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "9:45:00 AM"
  },
  {
    "sessionId": "11224",
    "sessionTitle": "Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology",
    "sessionStart": "1:30:00 PM",
    "sessionEnd": "2:00:00 PM"
  },
  {
    "sessionId": "11224",
    "sessionTitle": "Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology",
    "sessionStart": "1:30:00 PM",
    "sessionEnd": "2:00:00 PM"
  },
  {
    "sessionId": "11224",
    "sessionTitle": "Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology",
    "sessionStart": "1:30:00 PM",
    "sessionEnd": "2:00:00 PM"
  },
  {
    "sessionId": "11224",
    "sessionTitle": "Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology",
    "sessionStart": "1:30:00 PM",
    "sessionEnd": "2:00:00 PM"
  },
  {
    "sessionId": "11224",
    "sessionTitle": "Announcement of Awards: ASH Mentor Awards, ASH Award for Leadership in Promoting Diversity, ASH Outstanding Service Award, ASH Public Service Award, and Wallace H. Coulter Award for Lifetime Achievement in Hematology",
    "sessionStart": "1:30:00 PM",
    "sessionEnd": "2:00:00 PM"
  },
  {
    "sessionId": "11231",
    "sessionTitle": "Training Program Directors’ Workshop",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "5:00:00 PM"
  },
  {
    "sessionId": "11243",
    "sessionTitle": "How to Get Published in a Peer-Reviewed Journal",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11245",
    "sessionTitle": "Meet the Blood Editors",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11245",
    "sessionTitle": "Meet the Blood Editors",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11246",
    "sessionTitle": "Meet the Blood Editors",
    "sessionStart": "12:15:00 PM",
    "sessionEnd": "1:15:00 PM"
  },
  {
    "sessionId": "11246",
    "sessionTitle": "Meet the Blood Editors",
    "sessionStart": "12:15:00 PM",
    "sessionEnd": "1:15:00 PM"
  },
  {
    "sessionId": "11316",
    "sessionTitle": "Consultative Hematology Course",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "11:30:00 AM"
  },
  {
    "sessionId": "11316",
    "sessionTitle": "Consultative Hematology Course",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "11:30:00 AM"
  },
  {
    "sessionId": "11338",
    "sessionTitle": "Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11338",
    "sessionTitle": "Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11338",
    "sessionTitle": "Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11338",
    "sessionTitle": "Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11339",
    "sessionTitle": "Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies",
    "sessionStart": "11:45:00 AM",
    "sessionEnd": "12:45:00 PM"
  },
  {
    "sessionId": "11339",
    "sessionTitle": "Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies",
    "sessionStart": "11:45:00 AM",
    "sessionEnd": "12:45:00 PM"
  },
  {
    "sessionId": "11339",
    "sessionTitle": "Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies",
    "sessionStart": "11:45:00 AM",
    "sessionEnd": "12:45:00 PM"
  },
  {
    "sessionId": "11339",
    "sessionTitle": "Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies",
    "sessionStart": "11:45:00 AM",
    "sessionEnd": "12:45:00 PM"
  },
  {
    "sessionId": "11339",
    "sessionTitle": "Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies",
    "sessionStart": "11:45:00 AM",
    "sessionEnd": "12:45:00 PM"
  },
  {
    "sessionId": "11339",
    "sessionTitle": "Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies",
    "sessionStart": "11:45:00 AM",
    "sessionEnd": "12:45:00 PM"
  },
  {
    "sessionId": "11341",
    "sessionTitle": "Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11341",
    "sessionTitle": "Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11341",
    "sessionTitle": "Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11341",
    "sessionTitle": "Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11344",
    "sessionTitle": "Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11344",
    "sessionTitle": "Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11344",
    "sessionTitle": "Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11344",
    "sessionTitle": "Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11346",
    "sessionTitle": "Plasma Cells and Myeloma",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11347",
    "sessionTitle": "Platelet Clearance",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11349",
    "sessionTitle": "Contact Pathways in Health and Disease",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11351",
    "sessionTitle": "Next Generation Sequencing as a Diagnostic Tool for Precision Medicine",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11354",
    "sessionTitle": "The Role of Genetic Pathways in Bone Marrow Failure",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11355",
    "sessionTitle": "How Long to Anticoagulate My Patient With VTE",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11357",
    "sessionTitle": "Immune Thrombocytopenia",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11358",
    "sessionTitle": "Thrombotic Thrombocytopenic Purpura",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11359",
    "sessionTitle": "Aplastic Anemia",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11360",
    "sessionTitle": "ALL in Adolescents and Young Adults",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11361",
    "sessionTitle": "Individualized Therapy in Patients With AML",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11362",
    "sessionTitle": "Treating and Monitoring Patients With CML",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11363",
    "sessionTitle": "Novel Therapy Combinations in Multiple Myeloma",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11364",
    "sessionTitle": "Relapsed/Refractory Diffuse Large B-Cell Lymphoma",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11378",
    "sessionTitle": "Heparin-Induced Thrombocytopenia: HITs and Misses",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11379",
    "sessionTitle": "Tailored Therapy for Patients With Hodgkin Lymphoma",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11394",
    "sessionTitle": "Platelet Regulation of Tumor Growth and Metastasis",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11395",
    "sessionTitle": "Reversal of Anticoagulants",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11397",
    "sessionTitle": "Hematopoietic Stem Cell Generation, Reprogramming, and Expansion",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11399",
    "sessionTitle": "Best of ASH",
    "sessionStart": "11:30:00 AM",
    "sessionEnd": "1:00:00 PM"
  },
  {
    "sessionId": "11399",
    "sessionTitle": "Best of ASH",
    "sessionStart": "11:30:00 AM",
    "sessionEnd": "1:00:00 PM"
  },
  {
    "sessionId": "11399",
    "sessionTitle": "Best of ASH",
    "sessionStart": "11:30:00 AM",
    "sessionEnd": "1:00:00 PM"
  },
  {
    "sessionId": "11399",
    "sessionTitle": "Best of ASH",
    "sessionStart": "11:30:00 AM",
    "sessionEnd": "1:00:00 PM"
  },
  {
    "sessionId": "11400",
    "sessionTitle": "Genome Sequencing in the Newborn: Diagnostic Challenges and Emerging Opportunities",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11401",
    "sessionTitle": "Understanding Microbial Immune System Interactions",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11405",
    "sessionTitle": "Scholarly Work in Quality Improvement",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11405",
    "sessionTitle": "Scholarly Work in Quality Improvement",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11475",
    "sessionTitle": "101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11475",
    "sessionTitle": "101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Disordered Erythropoiesis",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11476",
    "sessionTitle": "101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11476",
    "sessionTitle": "101. Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron: Normal Erythropoiesis",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11477",
    "sessionTitle": "102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11477",
    "sessionTitle": "102. Regulation of Iron Metabolism: Iron homeostasis and related pathophysiology",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11478",
    "sessionTitle": "102. Regulation of Iron Metabolism: Iron and erythropoiesis",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11478",
    "sessionTitle": "102. Regulation of Iron Metabolism: Iron and erythropoiesis",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11479",
    "sessionTitle": "112. Thalassemia and Globin Gene Regulation I",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11479",
    "sessionTitle": "112. Thalassemia and Globin Gene Regulation I",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11480",
    "sessionTitle": "112. Thalassemia and Globin Gene Regulation II",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11480",
    "sessionTitle": "112. Thalassemia and Globin Gene Regulation II",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11481",
    "sessionTitle": "113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Hematopoiesis and Fetal Hemoglobin Augmentation",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11481",
    "sessionTitle": "113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Hematopoiesis and Fetal Hemoglobin Augmentation",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11482",
    "sessionTitle": "113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Pathophysiology and Investigational Therapies",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11482",
    "sessionTitle": "113. Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science: Sickle Cell Disease—Pathophysiology and Investigational Therapies",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11483",
    "sessionTitle": "114. Hemoglobinopathies, Excluding Thalassemia—Clinical I",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11483",
    "sessionTitle": "114. Hemoglobinopathies, Excluding Thalassemia—Clinical I",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11484",
    "sessionTitle": "114. Hemoglobinopathies, Excluding Thalassemia—Clinical II",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11484",
    "sessionTitle": "114. Hemoglobinopathies, Excluding Thalassemia—Clinical II",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11485",
    "sessionTitle": "114. Hemoglobinopathies, Excluding Thalassemia—Clinical III",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11485",
    "sessionTitle": "114. Hemoglobinopathies, Excluding Thalassemia—Clinical III",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11486",
    "sessionTitle": "201. Granulocytes, Monocytes, and Macrophages: SCN",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11486",
    "sessionTitle": "201. Granulocytes, Monocytes, and Macrophages: SCN",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11487",
    "sessionTitle": "201. Granulocytes, Monocytes, and Macrophages I",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11487",
    "sessionTitle": "201. Granulocytes, Monocytes, and Macrophages I",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11488",
    "sessionTitle": "203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11488",
    "sessionTitle": "203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: T cell biology and therapies",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11489",
    "sessionTitle": "203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11489",
    "sessionTitle": "203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: B cells and Innate Immunity",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11490",
    "sessionTitle": "301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11490",
    "sessionTitle": "301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Platelet Adhesion, Activation, and Biochemistry",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11491",
    "sessionTitle": "301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11491",
    "sessionTitle": "301. Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry: Vascular Wall Biology and Endothelial Cells",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11492",
    "sessionTitle": "311. Disorders of Platelet Number or Function: ITP: clinical aspects",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11492",
    "sessionTitle": "311. Disorders of Platelet Number or Function: ITP: clinical aspects",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11493",
    "sessionTitle": "311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11493",
    "sessionTitle": "311. Disorders of Platelet Number or Function: ITP: pathophysiologic considerations",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11494",
    "sessionTitle": "311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11494",
    "sessionTitle": "311. Disorders of Platelet Number or Function: Thrombosis in the setting of thrombocytopenia",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11495",
    "sessionTitle": "321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11495",
    "sessionTitle": "321. Blood Coagulation and Fibrinolytic Factors: Factor VIII, Factor X, and Factor V",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11496",
    "sessionTitle": "321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11496",
    "sessionTitle": "321. Blood Coagulation and Fibrinolytic Factors: Factor IX, FXII, FXIII, ADAMTS13, TFPI, and vWF",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11497",
    "sessionTitle": "322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11497",
    "sessionTitle": "322. Disorders of Coagulation or Fibrinolysis: Preclinical Studies in Bleeding Disorders",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11498",
    "sessionTitle": "322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11498",
    "sessionTitle": "322. Disorders of Coagulation or Fibrinolysis: Management of VWD and other Bleeding Disorders",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11499",
    "sessionTitle": "322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11499",
    "sessionTitle": "322. Disorders of Coagulation or Fibrinolysis: Novel Therapies and Clinical Trials in Bleeding Disorders",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11500",
    "sessionTitle": "331. Pathophysiology of Thrombosis I",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11500",
    "sessionTitle": "331. Pathophysiology of Thrombosis I",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11501",
    "sessionTitle": "331. Pathophysiology of Thrombosis II",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11501",
    "sessionTitle": "331. Pathophysiology of Thrombosis II",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11502",
    "sessionTitle": "332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11502",
    "sessionTitle": "332. Antithrombotic Therapy: Anticoagulation in Cancer and Beyond",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11503",
    "sessionTitle": "332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11503",
    "sessionTitle": "332. Antithrombotic Therapy: Thrombotic Outcomes in Special Populations",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11504",
    "sessionTitle": "401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11504",
    "sessionTitle": "401. Basic Science and Clinical Practice in Blood Transfusion: Dissecting pathophysiology in transfusion medicine using mouse models",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11505",
    "sessionTitle": "401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11505",
    "sessionTitle": "401. Basic Science and Clinical Practice in Blood Transfusion: Clinical and translational studies in transfusion medicine",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11506",
    "sessionTitle": "501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11506",
    "sessionTitle": "501. Hematopoietic Stem and Progenitor Biology: HSC maintenance and differentiation",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11507",
    "sessionTitle": "501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11507",
    "sessionTitle": "501. Hematopoietic Stem and Progenitor Biology: Extrinsic and intrinsic HSC signaling",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11508",
    "sessionTitle": "502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11508",
    "sessionTitle": "502. Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation: Genetics, metabolism, and cell cycle regulation",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11509",
    "sessionTitle": "506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11509",
    "sessionTitle": "506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment I",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11510",
    "sessionTitle": "506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11510",
    "sessionTitle": "506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells: Hematopoietic Microenvironment II",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11511",
    "sessionTitle": "508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11511",
    "sessionTitle": "508. Bone Marrow Failure: Inherited Bone Marrow Failure: Ribosomopathies and Related Disorders",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11512",
    "sessionTitle": "508. Bone Marrow Failure: Biology and Therapy",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11512",
    "sessionTitle": "508. Bone Marrow Failure: Biology and Therapy",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11513",
    "sessionTitle": "602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11513",
    "sessionTitle": "602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in acute myeloid leukemia",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11514",
    "sessionTitle": "602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11514",
    "sessionTitle": "602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered gene expression in myeloid and lymphoid leukemia",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11515",
    "sessionTitle": "602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11515",
    "sessionTitle": "602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Disordered epigenetic regulation in myeloid and lymphoid leukemia",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11516",
    "sessionTitle": "603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11516",
    "sessionTitle": "603. Oncogenes and Tumor Suppressors: Nuclear Export and Metabolic Regulation",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11517",
    "sessionTitle": "603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11517",
    "sessionTitle": "603. Oncogenes and Tumor Suppressors: Epigenetic and Post-Transcriptional Control",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11518",
    "sessionTitle": "604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11518",
    "sessionTitle": "604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11519",
    "sessionTitle": "604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11519",
    "sessionTitle": "604. Molecular Pharmacology and Drug Resistance in Myeloid Diseases: Novel Therapeutics and Mechanisms of Resistance in Myeloid Disease",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11520",
    "sessionTitle": "605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: ALL and T-cell malignancies",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11520",
    "sessionTitle": "605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: ALL and T-cell malignancies",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11521",
    "sessionTitle": "605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11521",
    "sessionTitle": "605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases: Chronic Lymphocytic Leukemia and other Lymphoid Diseases",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11522",
    "sessionTitle": "612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11522",
    "sessionTitle": "612. Acute Lymphoblastic Leukemia: Clinical Studies: Advances in the Treatment of ALL",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11523",
    "sessionTitle": "612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11523",
    "sessionTitle": "612. Acute Lymphoblastic Leukemia: Clinical Studies: Immune-based therapies and rare subgroups",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11524",
    "sessionTitle": "613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11524",
    "sessionTitle": "613. Acute Myeloid Leukemia: Clinical Studies: Advances in Frontline Therapy: Induction, Consolidation, and Maintenance",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11525",
    "sessionTitle": "613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11525",
    "sessionTitle": "613. Acute Myeloid Leukemia: Clinical Studies: Novel Therapies for AML and APL",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11526",
    "sessionTitle": "613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11526",
    "sessionTitle": "613. Acute Myeloid Leukemia: Clinical Studies: Risk Factors and Response-Adapted Personalized Medicine",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11527",
    "sessionTitle": "614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11527",
    "sessionTitle": "614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: CAR-T Cell Immunotherapy",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11528",
    "sessionTitle": "614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11528",
    "sessionTitle": "614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Therapy, Excluding CAR-T Cell",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11529",
    "sessionTitle": "615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11529",
    "sessionTitle": "615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Innovative AML Treatment with Approved Agents",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11530",
    "sessionTitle": "616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11530",
    "sessionTitle": "616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Emerging Molecularly-Targeted Therapies in AML",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11531",
    "sessionTitle": "616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11531",
    "sessionTitle": "616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Therapies for Elderly Patients with AML",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11532",
    "sessionTitle": "616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11532",
    "sessionTitle": "616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel Targeted and Immune-based Approaches in the Treatment of AML",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11533",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11533",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Promoting leukemogenesis and risk factors",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11534",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11534",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic and predictive markers",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11535",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11535",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Prognostic information and therapeutic implication",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11536",
    "sessionTitle": "618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11536",
    "sessionTitle": "618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Therapeutic targeting and clonal evolution in B-ALL",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11537",
    "sessionTitle": "618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11537",
    "sessionTitle": "618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Biology, Signaling Mechanisms, and Response in ALL",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11538",
    "sessionTitle": "618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11538",
    "sessionTitle": "618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Genetic and Metabolomic Profiling in ALL",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11539",
    "sessionTitle": "621. Lymphoma—Genetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11539",
    "sessionTitle": "621. Lymphoma—Genetic/Epigenetic Biology: Genomic characterization of lymphoma and beyond",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11540",
    "sessionTitle": "621. Lymphoma—Genetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11540",
    "sessionTitle": "621. Lymphoma—Genetic/Epigenetic Biology: Molecular approaches to describe, monitor, and target lymphoma",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11541",
    "sessionTitle": "622. Lymphoma Biology—Non-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11541",
    "sessionTitle": "622. Lymphoma Biology—Non-Genetic Studies: Novel Mechanisms Implicated in Lymphoma Biology",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11542",
    "sessionTitle": "622. Lymphoma Biology—Non-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11542",
    "sessionTitle": "622. Lymphoma Biology—Non-Genetic Studies: Prognostic Biomarkers and Immune Mechanisms in Lymphoma",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11543",
    "sessionTitle": "623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Follicular Lymphoma, First Line",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11543",
    "sessionTitle": "623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Follicular Lymphoma, First Line",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11544",
    "sessionTitle": "623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Mantle Cell Lymphoma, New Therapies",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11544",
    "sessionTitle": "623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Mantle Cell Lymphoma, New Therapies",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11545",
    "sessionTitle": "623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11545",
    "sessionTitle": "623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies: Indolent Lymphomas, Novel Therapies, and Diagnostics",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11546",
    "sessionTitle": "624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma—Chemotherapy and PET Studies",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11546",
    "sessionTitle": "624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma—Chemotherapy and PET Studies",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11547",
    "sessionTitle": "624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11547",
    "sessionTitle": "624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: Hodgkin Lymphoma Immunotherapy Studies; nodular lymphocyte predominant Hodgkin lymphoma clinical studies",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11548",
    "sessionTitle": "624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: T-Cell Lymphoma Clinical Studies",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11548",
    "sessionTitle": "624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies: T-Cell Lymphoma Clinical Studies",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11549",
    "sessionTitle": "625.  Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11549",
    "sessionTitle": "625.  Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: Novel targeted therapies for Non-Hodgkin's Lymphomas",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11550",
    "sessionTitle": "625. Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11550",
    "sessionTitle": "625. Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents: New Tools and Emerging Immune-Modulatory Approaches for Non-Hodgkin Lymphomas",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11551",
    "sessionTitle": "626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11551",
    "sessionTitle": "626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Immune-Based Therapeutic Approaches",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11552",
    "sessionTitle": "626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11552",
    "sessionTitle": "626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Novel Agents and Upfront Approaches",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11553",
    "sessionTitle": "627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11553",
    "sessionTitle": "627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: PET-Guided Therapy and Prognostic Models in Diffuse Large B-Cell Lymphoma",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11554",
    "sessionTitle": "627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11554",
    "sessionTitle": "627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Molecular Characterization of Diffuse Large B Cell Lymphoma",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11555",
    "sessionTitle": "627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11555",
    "sessionTitle": "627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Predicting Efficacy and Safety of CAR-T cells and Checkpoint Blockade",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11556",
    "sessionTitle": "627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11556",
    "sessionTitle": "627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies: Outcomes in Rare Entities: HTLV-1 ATLL, Gray Zone Lymphoma, Primary CNS Lymphoma, and Intravascular DLBCL",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11557",
    "sessionTitle": "631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11557",
    "sessionTitle": "631. Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy: Novel Targets and CML Stem Cell Biology",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11558",
    "sessionTitle": "632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11558",
    "sessionTitle": "632. Chronic Myeloid Leukemia: Therapy: Results of Clinical Trials",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11559",
    "sessionTitle": "632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11559",
    "sessionTitle": "632. Chronic Myeloid Leukemia: Therapy: NGS-based and Mechanistic Studies",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11560",
    "sessionTitle": "632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11560",
    "sessionTitle": "632. Chronic Myeloid Leukemia: Therapy: Treatment Discontinuation, Dose Reduction, and Prognostic Indicators",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11561",
    "sessionTitle": "634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11561",
    "sessionTitle": "634. Myeloproliferative Syndromes: Clinical: Biologic-Clinical Correlative Studies in MPNs, Including Transplant  ",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11562",
    "sessionTitle": "634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11562",
    "sessionTitle": "634. Myeloproliferative Syndromes: Clinical: Phase III and Long-Term Outcome Studies in MPNs",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11563",
    "sessionTitle": "634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11563",
    "sessionTitle": "634. Myeloproliferative Syndromes: Clinical: Phase I/II Trials of Novel Agents in MPNs",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11564",
    "sessionTitle": "635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11564",
    "sessionTitle": "635. Myeloproliferative Syndromes: Basic Science: Identification of novel targets for the treatment of myeloproliferative neoplasms",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11565",
    "sessionTitle": "635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11565",
    "sessionTitle": "635. Myeloproliferative Syndromes: Basic Science: Molecular events occurring within the myeloproliferative neoplasms",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11566",
    "sessionTitle": "636. Myelodysplastic Syndromes—Basic and Translational Studies: Immune and niche dysfunction in MDS",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11566",
    "sessionTitle": "636. Myelodysplastic Syndromes—Basic and Translational Studies: Immune and niche dysfunction in MDS",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11567",
    "sessionTitle": "636. Myelodysplastic Syndromes—Basic and Translational Studies: Molecular Mechanisms of MDS",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11567",
    "sessionTitle": "636. Myelodysplastic Syndromes—Basic and Translational Studies: Molecular Mechanisms of MDS",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11568",
    "sessionTitle": "637. Myelodysplastic Syndromes—Clinical Studies: Predicting Drug Response Using Novel Genomic Algorithms",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11568",
    "sessionTitle": "637. Myelodysplastic Syndromes—Clinical Studies: Predicting Drug Response Using Novel Genomic Algorithms",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11569",
    "sessionTitle": "637. Myelodysplastic Syndromes—Clinical Studies: Inflammation, Immunity, and Iron",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11569",
    "sessionTitle": "637. Myelodysplastic Syndromes—Clinical Studies: Inflammation, Immunity, and Iron",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11570",
    "sessionTitle": "637. Myelodysplastic Syndromes—Clinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11570",
    "sessionTitle": "637. Myelodysplastic Syndromes—Clinical Studies: Genes Inform Genes, Morphology, and Clinical Outcomes",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11571",
    "sessionTitle": "641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11571",
    "sessionTitle": "641. CLL: Biology and Pathophysiology, excluding Therapy: Therapeutic Resistance in CLL",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11572",
    "sessionTitle": "641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11572",
    "sessionTitle": "641. CLL: Biology and Pathophysiology, excluding Therapy: CLL in Its Microenvironment",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11573",
    "sessionTitle": "641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11573",
    "sessionTitle": "641. CLL: Biology and Pathophysiology, excluding Therapy: Epigenetics, Evolution, and the B Cell Receptor",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11574",
    "sessionTitle": "642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11574",
    "sessionTitle": "642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL Through Combinations of Novel Agents and Antibody ",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11575",
    "sessionTitle": "642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11575",
    "sessionTitle": "642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11576",
    "sessionTitle": "642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11576",
    "sessionTitle": "642. CLL: Therapy, excluding Transplantation: Targeting MRD Negative CLL with Combinations of Novel Agents and Chemoimmunotherapy Regimens, New Treatments",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11577",
    "sessionTitle": "651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11577",
    "sessionTitle": "651. Myeloma: Biology and Pathophysiology, excluding Therapy: New Insights into the Role of the Immune Microenvironment of Multiple Myeloma",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11578",
    "sessionTitle": "651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11578",
    "sessionTitle": "651. Myeloma: Biology and Pathophysiology, excluding Therapy: Transcriptional Regulatory Circuitries of Multiple Myeloma",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11579",
    "sessionTitle": "651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11579",
    "sessionTitle": "651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics of The Pathogenesis and Progression of Multiple Myeloma",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11580",
    "sessionTitle": "652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11580",
    "sessionTitle": "652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Novel Immunotherapeutic Strategies in Multiple Myeloma",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11581",
    "sessionTitle": "652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11581",
    "sessionTitle": "652. Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Emerging New Targets and Mechanisms of Resistance",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11582",
    "sessionTitle": "653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11582",
    "sessionTitle": "653. Myeloma: Therapy, excluding Transplantation: Immunotherapy in Myeloma and Amyloid",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11583",
    "sessionTitle": "653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11583",
    "sessionTitle": "653. Myeloma: Therapy, excluding Transplantation: Studies in Relapsed and Refractory Multiple Myeloma",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11584",
    "sessionTitle": "653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11584",
    "sessionTitle": "653. Myeloma: Therapy, excluding Transplantation: Upfront Therapy for Multiple Myeloma: Induction and Maintenance",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11585",
    "sessionTitle": "701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11585",
    "sessionTitle": "701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: T cell regeneration and donor graft effects on HCT",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11586",
    "sessionTitle": "701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11586",
    "sessionTitle": "701. Experimental Transplantation: Basic Biology, Pre-Clinical Models: Novel T cell targets in regulation of GVHD and GVL",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11587",
    "sessionTitle": "703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11587",
    "sessionTitle": "703. Adoptive Immunotherapy: Gene Engineered T cells for Hematologic Malignancies",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11588",
    "sessionTitle": "703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11588",
    "sessionTitle": "703. Adoptive Immunotherapy: Immune Therapeutics for Hematologic Cancers: Artificial Receptors and Beyond",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11589",
    "sessionTitle": "711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11589",
    "sessionTitle": "711. Cell Collection and Processing: Optimization of Hematopoietic Graft Using Small Molecules in Culture",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11590",
    "sessionTitle": "721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11590",
    "sessionTitle": "721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Alternative Donor Transplants",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11591",
    "sessionTitle": "721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11591",
    "sessionTitle": "721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Preparative Regimens ",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11592",
    "sessionTitle": "721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11592",
    "sessionTitle": "721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Microbiota, CMV, and GVHD",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11593",
    "sessionTitle": "722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11593",
    "sessionTitle": "722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Prevention",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11594",
    "sessionTitle": "722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11594",
    "sessionTitle": "722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Treatment",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11595",
    "sessionTitle": "722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11595",
    "sessionTitle": "722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Pathobiology",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11596",
    "sessionTitle": "723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11596",
    "sessionTitle": "723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: New strategies in diagnosis and therapy of malignancy relapse  ",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11597",
    "sessionTitle": "723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11597",
    "sessionTitle": "723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Progress in survivorship care of transplant patients ",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11598",
    "sessionTitle": "731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11598",
    "sessionTitle": "731. Clinical Autologous Transplantation: Results: Novel Conditioning & Maintenance Approaches",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11599",
    "sessionTitle": "731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11599",
    "sessionTitle": "731. Clinical Autologous Transplantation: Results: Modern Indications & Post-Transplant Check Point Inhibitors in Lymphoma and Myeloma",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11600",
    "sessionTitle": "732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11600",
    "sessionTitle": "732. Clinical Allogeneic Transplantation: Results: Donor Selection in the Haplo Transplant Era",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11601",
    "sessionTitle": "732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11601",
    "sessionTitle": "732. Clinical Allogeneic Transplantation: Results: Outcomes in Myeloid Leukemia and Impact of Conditioning",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11602",
    "sessionTitle": "801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11602",
    "sessionTitle": "801. Gene Therapy and Transfer: Immune Disorders, CAR-T Cells, and B-hemoglobinopathies",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11603",
    "sessionTitle": "801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11603",
    "sessionTitle": "801. Gene Therapy and Transfer: Gene Therapy for Hemophilia and Improving Lentiviral Vectors",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11604",
    "sessionTitle": "802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11604",
    "sessionTitle": "802. Chemical Biology and Experimental Therapeutics:  Functional Approaches for Diagnostics, Biomarker Development, and Discovery of New Targeting Strategies",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11605",
    "sessionTitle": "901. Health Services Research—Non-Malignant Conditions: Consultative Hematology",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11605",
    "sessionTitle": "901. Health Services Research—Non-Malignant Conditions: Consultative Hematology",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11606",
    "sessionTitle": "901. Health Services Research—Non-Malignant Conditions: Sickle Cell Disease",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11606",
    "sessionTitle": "901. Health Services Research—Non-Malignant Conditions: Sickle Cell Disease",
    "sessionStart": "9:30:00 AM",
    "sessionEnd": "11:00:00 AM"
  },
  {
    "sessionId": "11607",
    "sessionTitle": "901. Health Services Research—Non-Malignant Conditions: Thrombosis",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11607",
    "sessionTitle": "901. Health Services Research—Non-Malignant Conditions: Thrombosis",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11608",
    "sessionTitle": "902. Health Services Research—Malignant Diseases: Pediatric and AYA Outcomes",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11608",
    "sessionTitle": "902. Health Services Research—Malignant Diseases: Pediatric and AYA Outcomes",
    "sessionStart": "7:00:00 AM",
    "sessionEnd": "8:30:00 AM"
  },
  {
    "sessionId": "11609",
    "sessionTitle": "902. Health Services Research—Malignant Diseases: Race-Ethnic and Age-Related Disparities",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11609",
    "sessionTitle": "902. Health Services Research—Malignant Diseases: Race-Ethnic and Age-Related Disparities",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11610",
    "sessionTitle": "902. Health Services Research—Malignant Diseases: Adult Outcomes",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11610",
    "sessionTitle": "902. Health Services Research—Malignant Diseases: Adult Outcomes",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11611",
    "sessionTitle": "902. Health Services Research—Malignant Diseases: Innovative Predictors and Outcomes",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11611",
    "sessionTitle": "902. Health Services Research—Malignant Diseases: Innovative Predictors and Outcomes",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11612",
    "sessionTitle": "903. Outcomes Research—Non-Malignant Conditions: Sickle Cell Disease",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11612",
    "sessionTitle": "903. Outcomes Research—Non-Malignant Conditions: Sickle Cell Disease",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11613",
    "sessionTitle": "903. Outcomes Research—Non-Malignant Conditions: Health Impact and Mortality",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11613",
    "sessionTitle": "903. Outcomes Research—Non-Malignant Conditions: Health Impact and Mortality",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11614",
    "sessionTitle": "904. Outcomes Research—Malignant Conditions: Impacting Healthcare Utilization and End of Life Care",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11614",
    "sessionTitle": "904. Outcomes Research—Malignant Conditions: Impacting Healthcare Utilization and End of Life Care",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11615",
    "sessionTitle": "904. Outcomes Research—Malignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11615",
    "sessionTitle": "904. Outcomes Research—Malignant Conditions: Survivorship and Quality of Life in Lymphoid Malignancies",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11616",
    "sessionTitle": "904. Outcomes Research—Malignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11616",
    "sessionTitle": "904. Outcomes Research—Malignant Conditions: Impact of Disease Burden in Myeloma and Other Hematologic Malignancies",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11617",
    "sessionTitle": "904. Outcomes Research—Malignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11617",
    "sessionTitle": "904. Outcomes Research—Malignant Conditions: Quality Of Life and Outcomes in Myelodysplastic Syndromes and Leukemias",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11618",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11618",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11619",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11619",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis II",
    "sessionStart": "12:00:00 PM",
    "sessionEnd": "1:30:00 PM"
  },
  {
    "sessionId": "11620",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11620",
    "sessionTitle": "617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis III",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11622",
    "sessionTitle": "651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11622",
    "sessionTitle": "651. Myeloma: Biology and Pathophysiology, excluding Therapy: Mechanisms of Resistance and Prognosis ",
    "sessionStart": "4:00:00 PM",
    "sessionEnd": "5:30:00 PM"
  },
  {
    "sessionId": "11623",
    "sessionTitle": "651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11623",
    "sessionTitle": "651. Myeloma: Biology and Pathophysiology, excluding Therapy: Genomics ",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "11625",
    "sessionTitle": "653. Myeloma: Therapy, excluding Transplantation II",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11625",
    "sessionTitle": "653. Myeloma: Therapy, excluding Transplantation II",
    "sessionStart": "6:15:00 PM",
    "sessionEnd": "7:45:00 PM"
  },
  {
    "sessionId": "11626",
    "sessionTitle": "653. Myeloma: Therapy, excluding Transplantation I",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11626",
    "sessionTitle": "653. Myeloma: Therapy, excluding Transplantation I",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "4:15:00 PM"
  },
  {
    "sessionId": "11627",
    "sessionTitle": "732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11627",
    "sessionTitle": "732. Clinical Allogeneic Transplantation: Results: Transplant Outcomes",
    "sessionStart": "10:30:00 AM",
    "sessionEnd": "12:00:00 PM"
  },
  {
    "sessionId": "11628",
    "sessionTitle": "732. Clinical Allogeneic Transplantation: Results: GVH and GVL",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11628",
    "sessionTitle": "732. Clinical Allogeneic Transplantation: Results: GVH and GVL",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11718",
    "sessionTitle": "Identification of Germline Syndromes ",
    "sessionStart": "1:15:00 PM",
    "sessionEnd": "2:00:00 PM"
  },
  {
    "sessionId": "11718",
    "sessionTitle": "Identification of Germline Syndromes ",
    "sessionStart": "1:15:00 PM",
    "sessionEnd": "2:00:00 PM"
  },
  {
    "sessionId": "11719",
    "sessionTitle": "Novel Aspects of Known Predisposition Syndrome",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "2:45:00 PM"
  },
  {
    "sessionId": "11719",
    "sessionTitle": "Novel Aspects of Known Predisposition Syndrome",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "2:45:00 PM"
  },
  {
    "sessionId": "11720",
    "sessionTitle": "Emerging New Syndromes",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11720",
    "sessionTitle": "Emerging New Syndromes",
    "sessionStart": "2:45:00 PM",
    "sessionEnd": "3:30:00 PM"
  },
  {
    "sessionId": "11721",
    "sessionTitle": "Effects of Combinations of Germline Variants Including Penetrance/Molecular Progression",
    "sessionStart": "3:45:00 PM",
    "sessionEnd": "4:30:00 PM"
  },
  {
    "sessionId": "11721",
    "sessionTitle": "Effects of Combinations of Germline Variants Including Penetrance/Molecular Progression",
    "sessionStart": "3:45:00 PM",
    "sessionEnd": "4:30:00 PM"
  },
  {
    "sessionId": "11722",
    "sessionTitle": "Reporting of Families and Variant Interpretation",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "5:15:00 PM"
  },
  {
    "sessionId": "11722",
    "sessionTitle": "Reporting of Families and Variant Interpretation",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "5:15:00 PM"
  },
  {
    "sessionId": "11723",
    "sessionTitle": "Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes",
    "sessionStart": "5:15:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11723",
    "sessionTitle": "Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes",
    "sessionStart": "5:15:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11723",
    "sessionTitle": "Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes",
    "sessionStart": "5:15:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11723",
    "sessionTitle": "Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes",
    "sessionStart": "5:15:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11723",
    "sessionTitle": "Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes",
    "sessionStart": "5:15:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11723",
    "sessionTitle": "Point-Counter Point: Prophylactic Transplantation for Leukemia Predisposition Syndromes",
    "sessionStart": "5:15:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11727",
    "sessionTitle": "ASH-FDA Joint Symposium on New Drugs in Acute Myeloid Leukemia",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11729",
    "sessionTitle": "ASH-FDA Joint Symposium on New Drug Approvals in Acute Lymphoid Leukemia and Non-Hodgkin Lymphoma",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "6:00:00 PM"
  },
  {
    "sessionId": "11731",
    "sessionTitle": "Stem Cells ",
    "sessionStart": "1:05:00 PM",
    "sessionEnd": "1:50:00 PM"
  },
  {
    "sessionId": "11732",
    "sessionTitle": "Signaling and Developmental Hematopoiesis ",
    "sessionStart": "1:50:00 PM",
    "sessionEnd": "2:35:00 PM"
  },
  {
    "sessionId": "11732",
    "sessionTitle": "Signaling and Developmental Hematopoiesis ",
    "sessionStart": "1:50:00 PM",
    "sessionEnd": "2:35:00 PM"
  },
  {
    "sessionId": "11733",
    "sessionTitle": "Myeloid Malignancies",
    "sessionStart": "5:00:00 PM",
    "sessionEnd": "5:45:00 PM"
  },
  {
    "sessionId": "11734",
    "sessionTitle": "Transcription Factors/Epigenetics",
    "sessionStart": "4:15:00 PM",
    "sessionEnd": "5:00:00 PM"
  },
  {
    "sessionId": "11735",
    "sessionTitle": "New Investigators ",
    "sessionStart": "2:35:00 PM",
    "sessionEnd": "3:25:00 PM"
  },
  {
    "sessionId": "11737",
    "sessionTitle": "Stem Cells and Aging ",
    "sessionStart": "1:05:00 PM",
    "sessionEnd": "2:05:00 PM"
  },
  {
    "sessionId": "11738",
    "sessionTitle": "Aging, Inflammation and Immune Function ",
    "sessionStart": "2:20:00 PM",
    "sessionEnd": "3:05:00 PM"
  },
  {
    "sessionId": "11740",
    "sessionTitle": "Thrombosis and Aging",
    "sessionStart": "3:35:00 PM",
    "sessionEnd": "4:20:00 PM"
  },
  {
    "sessionId": "11741",
    "sessionTitle": "Clinical and Biologic Correlates of Frailty in Hematology",
    "sessionStart": "4:35:00 PM",
    "sessionEnd": "5:20:00 PM"
  },
  {
    "sessionId": "11747",
    "sessionTitle": "K2R Introductory Panel",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "2:30:00 PM"
  },
  {
    "sessionId": "11752",
    "sessionTitle": "Plenary Scientific Session",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11752",
    "sessionTitle": "Plenary Scientific Session",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11752",
    "sessionTitle": "Plenary Scientific Session",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11752",
    "sessionTitle": "Plenary Scientific Session",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11752",
    "sessionTitle": "Plenary Scientific Session",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11752",
    "sessionTitle": "Plenary Scientific Session",
    "sessionStart": "2:00:00 PM",
    "sessionEnd": "4:00:00 PM"
  },
  {
    "sessionId": "11902",
    "sessionTitle": "Opening Remarks",
    "sessionStart": "1:00:00 PM",
    "sessionEnd": "1:05:00 PM"
  },
  {
    "sessionId": "11902",
    "sessionTitle": "Opening Remarks",
    "sessionStart": "1:00:00 PM",
    "sessionEnd": "1:05:00 PM"
  },
  {
    "sessionId": "11903",
    "sessionTitle": "Opening Remarks",
    "sessionStart": "1:00:00 PM",
    "sessionEnd": "1:05:00 PM"
  },
  {
    "sessionId": "11903",
    "sessionTitle": "Opening Remarks",
    "sessionStart": "1:00:00 PM",
    "sessionEnd": "1:05:00 PM"
  },
  {
    "sessionId": "11906",
    "sessionTitle": "Opening Remarks ",
    "sessionStart": "1:00:00 PM",
    "sessionEnd": "1:15:00 PM"
  },
  {
    "sessionId": "11910",
    "sessionTitle": "Opening Remarks",
    "sessionStart": "1:00:00 PM",
    "sessionEnd": "1:05:00 PM"
  },
  {
    "sessionId": "11910",
    "sessionTitle": "Opening Remarks",
    "sessionStart": "1:00:00 PM",
    "sessionEnd": "1:05:00 PM"
  },
  {
    "sessionId": "11911",
    "sessionTitle": "Opening Remarks ",
    "sessionStart": "1:00:00 PM",
    "sessionEnd": "1:05:00 PM"
  },
  {
    "sessionId": "11911",
    "sessionTitle": "Opening Remarks ",
    "sessionStart": "1:00:00 PM",
    "sessionEnd": "1:05:00 PM"
  },
  {
    "sessionId": "11942",
    "sessionTitle": "Featured Topic: Hemophilia Revolution",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11942",
    "sessionTitle": "Featured Topic: Hemophilia Revolution",
    "sessionStart": "11:15:00 AM",
    "sessionEnd": "12:15:00 PM"
  },
  {
    "sessionId": "11943",
    "sessionTitle": "Featured Topic: Combination Therapies: How Are We Deciding What to Utilize?",
    "sessionStart": "1:15:00 PM",
    "sessionEnd": "2:15:00 PM"
  },
  {
    "sessionId": "11943",
    "sessionTitle": "Featured Topic: Combination Therapies: How Are We Deciding What to Utilize?",
    "sessionStart": "1:15:00 PM",
    "sessionEnd": "2:15:00 PM"
  },
  {
    "sessionId": "12020",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "2:05:00 PM",
    "sessionEnd": "2:20:00 PM"
  },
  {
    "sessionId": "12020",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "2:05:00 PM",
    "sessionEnd": "2:20:00 PM"
  },
  {
    "sessionId": "12020",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "2:05:00 PM",
    "sessionEnd": "2:20:00 PM"
  },
  {
    "sessionId": "12020",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "2:05:00 PM",
    "sessionEnd": "2:20:00 PM"
  },
  {
    "sessionId": "12021",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "3:05:00 PM",
    "sessionEnd": "3:20:00 PM"
  },
  {
    "sessionId": "12021",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "3:05:00 PM",
    "sessionEnd": "3:20:00 PM"
  },
  {
    "sessionId": "12021",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "3:05:00 PM",
    "sessionEnd": "3:20:00 PM"
  },
  {
    "sessionId": "12022",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "4:20:00 PM",
    "sessionEnd": "4:35:00 PM"
  },
  {
    "sessionId": "12022",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "4:20:00 PM",
    "sessionEnd": "4:35:00 PM"
  },
  {
    "sessionId": "12022",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "4:20:00 PM",
    "sessionEnd": "4:35:00 PM"
  },
  {
    "sessionId": "12023",
    "sessionTitle": "Closing Remarks ",
    "sessionStart": "5:35:00 PM",
    "sessionEnd": "5:40:00 PM"
  },
  {
    "sessionId": "12024",
    "sessionTitle": "Hemoglobin Thresholds and Population Health ",
    "sessionStart": "1:05:00 PM",
    "sessionEnd": "2:55:00 PM"
  },
  {
    "sessionId": "12026",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "5:20:00 PM",
    "sessionEnd": "5:35:00 PM"
  },
  {
    "sessionId": "12026",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "5:20:00 PM",
    "sessionEnd": "5:35:00 PM"
  },
  {
    "sessionId": "12026",
    "sessionTitle": "Panel Discussion/Questions",
    "sessionStart": "5:20:00 PM",
    "sessionEnd": "5:35:00 PM"
  },
  {
    "sessionId": "12032",
    "sessionTitle": "Panel Discussion",
    "sessionStart": "2:05:00 PM",
    "sessionEnd": "2:35:00 PM"
  },
  {
    "sessionId": "12032",
    "sessionTitle": "Panel Discussion",
    "sessionStart": "2:05:00 PM",
    "sessionEnd": "2:35:00 PM"
  },
  {
    "sessionId": "12033",
    "sessionTitle": "Panel Discussion",
    "sessionStart": "3:35:00 PM",
    "sessionEnd": "4:05:00 PM"
  },
  {
    "sessionId": "12033",
    "sessionTitle": "Panel Discussion",
    "sessionStart": "3:35:00 PM",
    "sessionEnd": "4:05:00 PM"
  },
  {
    "sessionId": "12034",
    "sessionTitle": "Panel Discussion",
    "sessionStart": "5:05:00 PM",
    "sessionEnd": "5:35:00 PM"
  },
  {
    "sessionId": "12034",
    "sessionTitle": "Panel Discussion",
    "sessionStart": "5:05:00 PM",
    "sessionEnd": "5:35:00 PM"
  },
  {
    "sessionId": "12035",
    "sessionTitle": "Closing Remarks ",
    "sessionStart": "5:35:00 PM",
    "sessionEnd": "5:40:00 PM"
  },
  {
    "sessionId": "12035",
    "sessionTitle": "Closing Remarks ",
    "sessionStart": "5:35:00 PM",
    "sessionEnd": "5:40:00 PM"
  },
  {
    "sessionId": "12037",
    "sessionTitle": "Late-Breaking Abstracts Session",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "12037",
    "sessionTitle": "Late-Breaking Abstracts Session",
    "sessionStart": "7:30:00 AM",
    "sessionEnd": "9:00:00 AM"
  },
  {
    "sessionId": "12040",
    "sessionTitle": "Hemoglobin Thresholds and Clinical Medicine",
    "sessionStart": "3:10:00 PM",
    "sessionEnd": "4:30:00 PM"
  },
  {
    "sessionId": "12041",
    "sessionTitle": "Conclusions and Study Needs",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "4:40:00 PM"
  },
  {
    "sessionId": "12041",
    "sessionTitle": "Conclusions and Study Needs",
    "sessionStart": "4:30:00 PM",
    "sessionEnd": "4:40:00 PM"
  },
  {
    "sessionId": "12042",
    "sessionTitle": "Closing Remarks ",
    "sessionStart": "4:40:00 PM",
    "sessionEnd": "4:45:00 PM"
  },
  {
    "sessionId": "12042",
    "sessionTitle": "Closing Remarks ",
    "sessionStart": "4:40:00 PM",
    "sessionEnd": "4:45:00 PM"
  },
  {
    "sessionId": "12046",
    "sessionTitle": "NHLBI Presentation ",
    "sessionStart": "3:25:00 PM",
    "sessionEnd": "3:35:00 PM"
  },
  {
    "sessionId": "12047",
    "sessionTitle": "NIDDK Presentation",
    "sessionStart": "3:35:00 PM",
    "sessionEnd": "3:45:00 PM"
  }
]
